Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
21/09/2026 13:41
BRIEF-HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication Sept 21 (Reuters) - HeartBeam, Inc. BEAT.O:
HEARTBEAM, - WILL NOT BUILD LARGE COMMERCIAL ORGANIZATION FOR ARRHYTHMIA INDICATION
HEARTBEAM, - REDIRECTS MAJORITY OF RESOURCES TOWARD HEART ATTACK DETECTION
Source text: ID:nBw34wFLZa
Further company coverage: BEAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartBeam
See all newsBrief: Heartbeam Receives FDA Breakthrough Device Designation For Heart Attack Assessment
Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance